JW
John Wilson Babu Chebrolu
About John Wilson Babu Chebrolu
John Wilson Babu Chebrolu has 23 years in corporate governance. Holds Additional Director and Director roles. Currently with 1 company, including Ksl Securities Private Limited and Lorven Solutions Private Limited. Formerly with 2 companies, such as Bandaram Pharma Packtech Limited. Engaged in General Business, Technology. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Ksl Securities Private Limited
U67120TG1998PTC030560
|
Additional Director | 25 May 2015 | 1998 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Bandaram Pharma Packtech Limited
L93090KA1993PLC159827
|
Additional Director | 24 Mar 2012 | 1993 | Active |
Lorven Solutions Private Limited
U72200TG2000PTC033271
|
Director | 31 Mar 2003 | 2000 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for John Wilson Babu Chebrolu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about John Wilson Babu Chebrolu
John Wilson Babu Chebrolu has 23 years in corporate governance. Holds Additional Director and Director roles. Currently with 1 company, including Ksl Securities Private Limited and Lorven Solutions Private Limited. Formerly with 2 companies, such as Bandaram Pharma Packtech Limited. Engaged in General Business, Technology. Contributes to corporate operations.
John Wilson Babu Chebrolu is associated with 1 company as Additional Director and Director.
John Wilson Babu Chebrolu has expertise in General Business, Technology.
John Wilson Babu Chebrolu has 23 years in corporate governance.